The need to develop health data transaction disclosure requirements to balance transparency, privacy, and progressive use

The Lancet Digital Health

Matthew G Crowson MD MBI, Jade Z H Tan, Jessilyn Dunn PhD, Jay Bhatt MD, Zachary Schneider, Daniel Forger PhD, Leo A Celi MD MPH, Matilda Dorotic PhD, Prof Bradley Malin

Lancet cover

Summary

This Viewpoint critically evaluates the impact of commodifying health data in the era of electronic health records and the ethical challenges this practice raises. Additionally, the Viewpoint explores the complex interplay between the advancement of health-care artificial intelligence (AI) and the imperative for transparency in data practices, scrutinising the insufficiency of existing regulations in addressing the nuances of health data transactions. The January, 2025 US executive order on AI further emphasises the need for stringent data management and privacy measures, supporting our call for a patient-centric approach to data handling. Moreover, we advocate for comprehensive regulatory frameworks that promote transparency, protect patient data, and maintain trust in health technologies. Such efforts contribute to a health-care environment where data stewardship is synonymous with integrity and respect for patient rights.

Citation

Crowson, Matthew G., et al. “The need to develop health data transaction disclosure requirements to balance transparency, privacy, and progressive use.” The Lancet Digital Health (2026).

BibTex

@article{crowson2026need, title={The need to develop health data transaction disclosure requirements to balance transparency, privacy, and progressive use}, author={Crowson, Matthew G and Tan, Jade ZH and Dunn, Jessilyn and Bhatt, Jay and Schneider, Zachary and Forger, Daniel and Celi, Leo A and Dorotic, Matilda and Malin, Bradley}, journal={The Lancet Digital Health}, year={2026}, publisher={Elsevier} }

Collaborators:

Referenced Research: